Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Germline Variants of CYBA and TRPM4 Predispose to Familial Colorectal Cancer

L. Zhu, B. Miao, D. Dymerska, M. Kuswik, E. Bueno-Martínez, L. Sanoguera-Miralles, EA. Velasco, N. Paramasivam, M. Schlesner, A. Kumar, Y. Yuan, J. Lubinski, OR. Bandapalli, K. Hemminki, A. Försti

. 2022 ; 14 (3) : . [pub] 20220128

Language English Country Switzerland

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc22010122

Grant support
Horizon 2020 European Union
CA17118 European Cooperation in Science and Technology

Familial colorectal cancer (CRC) is only partially explained by known germline predisposing genes. We performed whole-genome sequencing in 15 Polish families of many affected individuals, without mutations in known CRC predisposing genes. We focused on loss-of-function variants and functionally characterized them. We identified a frameshift variant in the CYBA gene (c.246delC) in one family and a splice site variant in the TRPM4 gene (c.25-1 G > T) in another family. While both variants were absent or extremely rare in gene variant databases, we identified four additional Polish familial CRC cases and two healthy elderly individuals with the CYBA variant (odds ratio 2.46, 95% confidence interval 0.48-12.69). Both variants led to a premature stop codon and to a truncated protein. Functional characterization of the variants showed that knockdown of CYBA or TRPM4 depressed generation of reactive oxygen species (ROS) in LS174T and HT-29 cell lines. Knockdown of TRPM4 resulted in decreased MUC2 protein production. CYBA encodes a component in the NADPH oxidase system which generates ROS and controls, e.g., bacterial colonization in the gut. Germline CYBA variants are associated with early onset inflammatory bowel disease, supported with experimental evidence on loss of intestinal mucus barrier function due to ROS deficiency. TRPM4 encodes a calcium-activated ion channel, which, in a human colonic cancer cell line, controls calcium-mediated secretion of MUC2, a major component of intestinal mucus barrier. We suggest that the gene defects in CYBA and TRPM4 mechanistically involve intestinal barrier integrity through ROS and mucus biology, which converges in chronic bowel inflammation.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22010122
003      
CZ-PrNML
005      
20220425131713.0
007      
ta
008      
220420s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/cancers14030670 $2 doi
035    __
$a (PubMed)35158942
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Zhu, Lizhen $u Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany $u Department of Medical Oncology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China $1 https://orcid.org/0000000313716801
245    10
$a Germline Variants of CYBA and TRPM4 Predispose to Familial Colorectal Cancer / $c L. Zhu, B. Miao, D. Dymerska, M. Kuswik, E. Bueno-Martínez, L. Sanoguera-Miralles, EA. Velasco, N. Paramasivam, M. Schlesner, A. Kumar, Y. Yuan, J. Lubinski, OR. Bandapalli, K. Hemminki, A. Försti
520    9_
$a Familial colorectal cancer (CRC) is only partially explained by known germline predisposing genes. We performed whole-genome sequencing in 15 Polish families of many affected individuals, without mutations in known CRC predisposing genes. We focused on loss-of-function variants and functionally characterized them. We identified a frameshift variant in the CYBA gene (c.246delC) in one family and a splice site variant in the TRPM4 gene (c.25-1 G > T) in another family. While both variants were absent or extremely rare in gene variant databases, we identified four additional Polish familial CRC cases and two healthy elderly individuals with the CYBA variant (odds ratio 2.46, 95% confidence interval 0.48-12.69). Both variants led to a premature stop codon and to a truncated protein. Functional characterization of the variants showed that knockdown of CYBA or TRPM4 depressed generation of reactive oxygen species (ROS) in LS174T and HT-29 cell lines. Knockdown of TRPM4 resulted in decreased MUC2 protein production. CYBA encodes a component in the NADPH oxidase system which generates ROS and controls, e.g., bacterial colonization in the gut. Germline CYBA variants are associated with early onset inflammatory bowel disease, supported with experimental evidence on loss of intestinal mucus barrier function due to ROS deficiency. TRPM4 encodes a calcium-activated ion channel, which, in a human colonic cancer cell line, controls calcium-mediated secretion of MUC2, a major component of intestinal mucus barrier. We suggest that the gene defects in CYBA and TRPM4 mechanistically involve intestinal barrier integrity through ROS and mucus biology, which converges in chronic bowel inflammation.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Miao, Beiping $u Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany $u Hopp Children's Cancer Center (KiTZ), D-69120 Heidelberg, Germany $u Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), D-69120 Heidelberg, Germany
700    1_
$a Dymerska, Dagmara $u Department of Genetics and Pathology, Hereditary Cancer Center, Pomeranian Medical University, Unii Lubelskiej 1, 71-252 Szczecin, Poland
700    1_
$a Kuswik, Magdalena $u Department of Genetics and Pathology, Hereditary Cancer Center, Pomeranian Medical University, Unii Lubelskiej 1, 71-252 Szczecin, Poland
700    1_
$a Bueno-Martínez, Elena $u Splicing and Genetic Susceptibility to Cancer, Instituto de Biología y Genética Molecular (CSIC-UVa), 47003 Valladolid, Spain $1 https://orcid.org/0000000348882885
700    1_
$a Sanoguera-Miralles, Lara $u Splicing and Genetic Susceptibility to Cancer, Instituto de Biología y Genética Molecular (CSIC-UVa), 47003 Valladolid, Spain $1 https://orcid.org/0000000255487114
700    1_
$a Velasco, Eladio A $u Splicing and Genetic Susceptibility to Cancer, Instituto de Biología y Genética Molecular (CSIC-UVa), 47003 Valladolid, Spain $1 https://orcid.org/0000000296825589
700    1_
$a Paramasivam, Nagarajan $u Computational Oncology, Molecular Diagnostics Program, National Center for Tumor Diseases (NCT), D-69120 Heidelberg, Germany
700    1_
$a Schlesner, Matthias $u Bioinformatics and Omics Data Analytics, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany $1 https://orcid.org/0000000258964086
700    1_
$a Kumar, Abhishek $u Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany $u Institute of Bioinformatics, International Technology Park, Bengaluru 560066, India $u Manipal Academy of Higher Education (MAHE), Manipal 576104, India $1 https://orcid.org/0000000341724059
700    1_
$a Yuan, Ying $u Department of Medical Oncology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China
700    1_
$a Lubinski, Jan $u Department of Genetics and Pathology, Hereditary Cancer Center, Pomeranian Medical University, Unii Lubelskiej 1, 71-252 Szczecin, Poland $1 https://orcid.org/0000000329313003
700    1_
$a Bandapalli, Obul Reddy $u Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany $u Hopp Children's Cancer Center (KiTZ), D-69120 Heidelberg, Germany $u Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), D-69120 Heidelberg, Germany $u Medical Faculty Heidelberg, Heidelberg University, D-69120 Heidelberg, Germany $1 https://orcid.org/0000000211321745
700    1_
$a Hemminki, Kari $u Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany $u Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, 30605 Pilsen, Czech Republic $u Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany $1 https://orcid.org/0000000227693316
700    1_
$a Försti, Asta $u Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany $u Hopp Children's Cancer Center (KiTZ), D-69120 Heidelberg, Germany $u Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), D-69120 Heidelberg, Germany $1 https://orcid.org/0000000298574728
773    0_
$w MED00173178 $t Cancers $x 2072-6694 $g Roč. 14, č. 3 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35158942 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220420 $b ABA008
991    __
$a 20220425131710 $b ABA008
999    __
$a ind $b bmc $g 1784492 $s 1161320
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 14 $c 3 $e 20220128 $i 2072-6694 $m Cancers $n Cancers $x MED00173178
GRA    __
$a Horizon 2020 $p European Union
GRA    __
$a CA17118 $p European Cooperation in Science and Technology
LZP    __
$a Pubmed-20220420

Find record

Citation metrics

Archiving options